ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 65 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $329,000 | -15.0% | 67,118 | -8.4% | 0.00% | – |
| Q2 2021 | $387,000 | -76.2% | 73,233 | -78.4% | 0.00% | – |
| Q1 2021 | $1,626,000 | -66.1% | 338,714 | -69.4% | 0.00% | -100.0% |
| Q4 2020 | $4,794,000 | +288.8% | 1,107,225 | +270.0% | 0.00% | – |
| Q3 2020 | $1,233,000 | +38.2% | 299,274 | -14.0% | 0.00% | – |
| Q2 2020 | $892,000 | -40.1% | 348,150 | -32.4% | 0.00% | – |
| Q1 2020 | $1,489,000 | +1100.8% | 515,097 | +1474.2% | 0.00% | – |
| Q4 2019 | $124,000 | +77.1% | 32,721 | +139.2% | 0.00% | – |
| Q3 2019 | $70,000 | +600.0% | 13,681 | +812.7% | 0.00% | – |
| Q2 2019 | $10,000 | -82.8% | 1,499 | -81.5% | 0.00% | – |
| Q1 2019 | $58,000 | -98.8% | 8,097 | -98.5% | 0.00% | -100.0% |
| Q4 2018 | $4,734,000 | +390.6% | 554,269 | +1050.2% | 0.00% | – |
| Q3 2018 | $965,000 | -47.6% | 48,188 | -32.4% | 0.00% | – |
| Q2 2018 | $1,841,000 | +16.3% | 71,285 | +7.6% | 0.00% | – |
| Q1 2018 | $1,583,000 | -77.1% | 66,240 | -67.5% | 0.00% | -100.0% |
| Q4 2017 | $6,915,000 | +960.6% | 204,016 | +562.7% | 0.00% | – |
| Q3 2017 | $652,000 | +38.1% | 30,786 | +13.9% | 0.00% | – |
| Q2 2017 | $472,000 | -55.6% | 27,040 | -55.5% | 0.00% | – |
| Q1 2017 | $1,062,000 | -43.8% | 60,696 | -45.7% | 0.00% | – |
| Q4 2016 | $1,888,000 | +898.9% | 111,856 | +870.1% | 0.00% | – |
| Q3 2016 | $189,000 | +626.9% | 11,530 | +562.3% | 0.00% | – |
| Q2 2016 | $26,000 | -69.4% | 1,741 | -70.5% | 0.00% | – |
| Q1 2016 | $85,000 | -63.8% | 5,900 | -29.0% | 0.00% | – |
| Q4 2015 | $235,000 | +65.5% | 8,307 | -2.2% | 0.00% | – |
| Q3 2015 | $142,000 | -54.8% | 8,497 | -29.0% | 0.00% | – |
| Q2 2015 | $314,000 | +19.8% | 11,971 | -20.1% | 0.00% | – |
| Q1 2015 | $262,000 | -41.1% | 14,978 | -41.5% | 0.00% | – |
| Q4 2014 | $445,000 | +6257.1% | 25,625 | +6290.3% | 0.00% | – |
| Q3 2014 | $7,000 | -96.4% | 401 | -96.2% | 0.00% | – |
| Q2 2014 | $192,000 | – | 10,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|